J Korean Med Sci.  2008 Apr;23(2):350-354. 10.3346/jkms.2008.23.2.350.

Catastrophic Catecholamine-Induced Cardiomyopathy Mimicking Acute Myocardial Infarction, Rescued by Extracorporeal Membrane Oxygenation (ECMO) in Pheochromocytoma

Affiliations
  • 1Department of Medicine, Division of Cardiology, Asan Medical Center, University of Ulsan, Seoul, Korea. sjpark@amc.seoul.kr
  • 2Department of Cardiothoracic Surgery, Asan Medical Center, University of Ulsan, Seoul, Korea.

Abstract

Pheochromocytoma is a rare disorder and functioning tumor composed of chromaffin cells that secrete catecholamines. Patients with a pheochromocytoma 'crisis' have a high mortality in spite of aggressive therapy. We present a case with a severe acute catecholamine cardiomyopathy presenting ST segment elevation with cardiogenic shock after hemorrhage into a left suprarenal tumor. Intra-aortic balloon pump (IABP) support, combined with inotropic therapy, was performed. However, the patient deteriorated rapidly and was unresponsive to a full dose of inotropics and IABP. We decided to apply extracorporeal membrane oxygenation (ECMO) device for the patient. His clinical state began to improve 3 days after ECMO. After achieving hemodynamic stabilization, he underwent successful laparoscopic left adrenalectomy. He needed no further cardiac medication after discharge.

Keyword

Shock, Cardiogenic; Catecholamines; Intra-Aortic Balloon Pumping; Extracorporeal Membrane Oxygenation; Pheochromocytoma

MeSH Terms

Adrenal Glands/pathology
Adult
Cardiomyopathies/*diagnosis/*etiology
Catecholamines/*adverse effects
Coronary Angiography/methods
Diagnosis, Differential
Electrocardiography/methods
Extracorporeal Membrane Oxygenation/*methods
Humans
Intra-Aortic Balloon Pumping
Male
Myocardial Infarction/*diagnosis
Pheochromocytoma/*therapy
Time Factors
Tomography, X-Ray Computed/methods

Figure

  • Fig. 1 (A) Initial ECG at emergency room showed left ventricular hypertrophy and ST depression in precordial leads. (B) Follow-up ECG showed ST elevation when abrupt hypotension occurred.

  • Fig. 2 The trend of cardiac enzymes.

  • Fig. 3 Coronary angiography shows near-normal coronary artery. (A) Right coronary artery and (B) Left coronary arteries.

  • Fig. 4 The graph shows the typical hemodynamic pattern of an acute cardiac events: a low SBP with the need for aggressive inotropic support and with good response to inotrophic agents. IABP and ECMO support and fluid therapy restored cardiac output during the first three days. Continuous cardiogenic shock was treated with dobutamine and norepinephrine temporarily. Continuous inotropic agents were discontinued at day 5. IABP, intra-aortic balloon pump, ECMO, extracorporeal membrane oxygenation, SBP, systolic blood pressure.

  • Fig. 5 (A) Abdominal computed tomography (CT) scan shows multiple sepated and well-encapsulated mass with intratumoral hemorrhage. (B) Three years later CT showed an enhanced 4.2×3.5 ×3 cm sized mass with septated central necrosis (comparison between 2002 and 2005, arrows indicate tumors).

  • Fig. 6 Left adrenal gland is a lump of soft mass (4.2×3.5×3 cm) with weight 28 gm. The cut surface of the mass is yellowish tan and soft with central hemorrhagic and necrotic areas.

  • Fig. 7 ECG after removal of tumor showed left ventricular hypertrophy without ST change.


Cited by  2 articles

Catecholamine-Induced Cardiomyopathy associated with Neuroblastoma and Treated with Extracorporeal Membrane Oxygenation as a Bridge to Recovery
Junggu Yi, Si Oh Kim, Jun-mo Park, Sung-hye Byun, Hoon Jung, Seong Wook Hong
Korean J Crit Care Med. 2015;30(4):299-302.    doi: 10.4266/kjccm.2015.30.4.299.

Catastrophic catecholamine-induced cardiomyopathy rescued by extracorporeal membrane oxygenation in recurrent malignant pheochromocytoma
Daniel Min
Yeungnam Univ J Med. 2019;36(3):254-259.    doi: 10.12701/yujm.2019.00213.


Reference

1. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005. 366:665–675.
Article
2. Plouin PF, Degoulet P, Tugayé A, Ducrocq MB, Ménard J. [Screening for phaeochromocytoma: in which hypertensive patients? A semiological study of 2585 patients, including 11 with phaeochromocytoma (author's transl). Nouv Presse Med. 1981. 10:869–872.
3. Schifferdecker B, Kodali D, Hausner E, Aragam J. Adrenergic shock-an overlooked clinical entity? Cardiol Rev. 2005. 13:69–72.
4. Sardesai SH, Mourant AJ, Sivathandon Y, Farrow R, Gibbons DO. Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. Br Heart J. 1990. 63:234–237.
Article
5. Huddle KR, Kalliatakis B, Skoularigis J. Pheochromocytoma associated with clinical and echocardiographic features simulating hypertrophic obstructive cardiomyopathy. Chest. 1996. 109:1394–1397.
Article
6. Gupta KK. Letter: Phaeochromocytoma and myocardial infarction. Lancet. 1975. 1:281–282.
7. Nirgiotis JG, Andrassy RJ. Pheochromocytoma and acute myocardial infarction. South Med J. 1990. 83:1478–1480.
Article
8. Szakacs JE, Cannon A. L-Norepinephrine myocarditis. Am J Clin Pathol. 1958. 30:425–434.
Article
9. Kline IK. Myocardial alterations associated with pheochromocytomas. Am J Pathol. 1961. 38:539–551.
10. Seeley E WG. The heart in endocrine disorders. Braunwald's heart disease: a textbook of cardiovascular medicine. 2005. 7th ed. New York: W.B. Saunders Co.;2063–2064. .
11. Sayer WJ, Moser M, Mattingly TW. Pheochromocytoma and the abnormal electrocardiogram. Am Heart J. 1954. 48:42–53.
Article
12. Shimizu K, Miura Y, Meguro Y, Noshio T, Ohzeki T, Kusakari T, Akama H, Watanabe T, Honma H, Imai Y. QT prolongation with torsade de pointes in pheochromocytoma. Am Heart J. 1992. 124:235–239.
Article
13. Haas GJ, Tzagournis M, Boudoulas H. Pheochromocytoma: catecholamine-mediated electrocardiographic changes mimicking ischemia. Am Heart J. 1988. 116:1363–1365.
Article
14. Cheng TO, Bashour TT. Striking electrocardiographic changes associated with pheochromocytoma. Masquerading as ischemic heart disease. Chest. 1976. 70:397–399.
15. McManus BM, Fleury TA, Roberts WC. Fatal catecholamine crisis in pheochromocytoma: curable cause of cardiac arrest. Am Heart J. 1981. 102:930–932.
Article
16. Delaney JP, Paritzky AZ. Necrosis of a pheochromocytoma with shock. N Engl J Med. 1969. 280:1394–1395.
Article
17. Duh QY. Evolving surgical management for patients with pheochromocytoma. J Clin Endocrinol Metab. 2001. 86:1477–1479.
Article
18. Dembitsky WP, Moreno-Cabral RJ, Adamson RM, Daily PO. Emergency resuscitation using portable extracorporeal membrane oxygenation. Ann Thorac Surg. 1993. 55:304–309.
Article
19. Chen YS, Wang MJ, Chou NK, Han YY, Chiu IS, Lin FY, Chu SH, Ko WJ. Rescue for acute myocarditis with shock by extracorporeal membrane oxygenation. Ann Thorac Surg. 1999. 68:2220–2224.
Article
20. Takagi S, Miyazaki S, Fujii T, Daikoku S, Sutani Y, Morii I, Yasuda S, Goto Y, Nonogi H. Dexamethasone-induced cardiogenic shock rescued by percutaneous cardiopulmonary support (PCPS) in a patient with pheochromocytoma. Jpn Circ J. 2000. 64:785–788.
Article
21. Shen WT, Sturgeon C, Clark OH, Duh QY, Kebebew E. Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas. Surgery. 2004. 136:1129–1137.
Article
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr